NATALIA LAPTEVA's research topics

NATALIA LAPTEVA

Concepts (193)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with NATALIA LAPTEVA's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that NATALIA LAPTEVA has written about over time.

Toll-Like Receptor 4, 1 publications between 2007 and 2007, average publication date October 2007. Cancer Vaccines, 6 publications between 2006 and 2011, average publication date February 2009. Oncolytic Viruses, 2 publications between 2009 and 2009, average publication date April 2009. Dendritic Cells, 8 publications between 2006 and 2011, average publication date August 2009. CD40 Antigens, 3 publications between 2007 and 2011, average publication date September 2009. Chemokine CCL5, 2 publications between 2009 and 2010, average publication date September 2009. Adjuvants, Immunologic, 2 publications between 2010 and 2011, average publication date October 2010. Adenoviridae, 5 publications between 2009 and 2019, average publication date July 2012. Neoplasms, 5 publications between 2009 and 2022, average publication date January 2013. Transduction, Genetic, 3 publications between 2010 and 2016, average publication date June 2013. Cell Proliferation, 4 publications between 2009 and 2016, average publication date September 2013. Cell Culture Techniques, 2 publications between 2012 and 2016, average publication date April 2014. Killer Cells, Natural, 8 publications between 2009 and 2019, average publication date September 2014. K562 Cells, 3 publications between 2012 and 2019, average publication date November 2015. Receptors, Antigen, T-Cell, 3 publications between 2017 and 2019, average publication date September 2018. Immunotherapy, Adoptive, 9 publications between 2012 and 2024, average publication date January 2019. Lymphoma, B-Cell, 1 publications between 2019 and 2019, average publication date September 2019. T-Lymphocytes, 5 publications between 2012 and 2024, average publication date December 2019. Antigens, CD19, 2 publications between 2019 and 2024, average publication date December 2021.

Toll-Like Receptor 4
Cancer Vaccines
Oncolytic Viruses
Dendritic Cells
CD40 Antigens
Chemokine CCL5
Adjuvants, Immunologic
Adenoviridae
Neoplasms
Transduction, Genetic
Cell Proliferation
Cell Culture Techniques
Killer Cells, Natural
K562 Cells
Receptors, Antigen, T-Cell
Immunotherapy, Adoptive
Lymphoma, B-Cell
T-Lymphocytes
Antigens, CD19

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
Toll-Like Receptor 4	1	2007	2007	October 2007
Cancer Vaccines	6	2006	2011	February 2009
Oncolytic Viruses	2	2009	2009	April 2009
Dendritic Cells	8	2006	2011	August 2009
CD40 Antigens	3	2007	2011	September 2009
Chemokine CCL5	2	2009	2010	September 2009
Adjuvants, Immunologic	2	2010	2011	October 2010
Adenoviridae	5	2009	2019	July 2012
Neoplasms	5	2009	2022	January 2013
Transduction, Genetic	3	2010	2016	June 2013
Cell Proliferation	4	2009	2016	September 2013
Cell Culture Techniques	2	2012	2016	April 2014
Killer Cells, Natural	8	2009	2019	September 2014
K562 Cells	3	2012	2019	November 2015
Receptors, Antigen, T-Cell	3	2017	2019	September 2018
Immunotherapy, Adoptive	9	2012	2024	January 2019
Lymphoma, B-Cell	1	2019	2019	September 2019
T-Lymphocytes	5	2012	2024	December 2019
Antigens, CD19	2	2019	2024	December 2021

LAPTEVA's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (193)

Explore

Co-Authors (46)

Explore

Similar People (60)

Explore

Same Department

Explore

Physical Neighbors